Rise Health's peptide therapy claims need more evidence

What does this Rise Health video actually claim?

The @risehealth_ Instagram video makes broad promises about "personalized treatment plans" and peptide therapy without specifying what conditions they treat or what outcomes patients can expect. The post uses hashtags like #peptidetherapy and #hormones while offering a free consultation with the promotional code "SLAYER."

The video doesn't make explicit medical claims about peptides like BPC-157 or TB-500. Instead, it focuses on vague wellness language about "taking control" and "feeling better today." This marketing approach lets them promote peptide services without making specific therapeutic claims that would require FDA approval.

What's the evidence for peptide therapy?

Most peptides marketed by wellness clinics lack strong human clinical trials. BPC-157, one of the most popular peptides, has shown promise in animal studies for tissue repair, but human data is extremely limited.

The FDA has explicitly warned about compounded peptides. In 2023, they issued guidance stating that peptides like BPC-157 and TB-500 don't meet approval requirements and can't be legally prescribed as compounded medications. CJC-1295 and ipamorelin, growth hormone-releasing peptides, face similar regulatory issues.

Some peptides do have legitimate medical uses. Semaglutide and tirzepatide are FDA-approved peptides for diabetes and weight loss. But the trendy "research peptides" promoted by many telehealth clinics operate in a regulatory gray area with minimal safety data.

What are the actual risks?

Compounded peptides aren't subject to the same quality controls as FDA-approved drugs. Purity, potency, and sterility can vary between batches and manufacturers.

Many peptides require injection, which carries infection risks if proper sterile technique isn't followed. Some patients experience injection site reactions, nausea, or other side effects. Long-term safety data simply doesn't exist for most research peptides.

The bigger concern is that patients might delay proven treatments while experimenting with unproven peptides. If you're dealing with a real medical condition, established therapies with known safety profiles usually make more sense than experimental compounds.

What should you know about telehealth peptide clinics?

Many telehealth platforms market peptides as "optimization" rather than treatment to avoid FDA oversight. This doesn't mean the compounds are safer or more effective.

Legitimate peptide therapy exists for specific conditions. Growth hormone deficiency, for example, can be treated with approved peptides under proper medical supervision. But most wellness applications lack evidence.

Before considering peptide therapy, ask providers for specific studies supporting their protocols. If they can't cite human clinical trials with meaningful endpoints, that's a red flag. Also verify that any peptides prescribed are actually legal to compound and dispense in your state.